Spots Global Cancer Trial Database for hec
Every month we try and update this database with for hec cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients | NCT01554943 | Breast Cancer | cardiac MRI | 18 Years - 90 Years | Jules Bordet Institute | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center | |
| CV Events in Emetogenic Chemotherapy | NCT01366599 | Vomiting Cardiovascular ... Arterial Thromb... | HEC or MEC | - | GlaxoSmithKline | |
| Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients | NCT01554943 | Breast Cancer | cardiac MRI | 18 Years - 90 Years | Jules Bordet Institute | |
| Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | NCT01640340 | Malignant Neopl... | aprepitant palonosetron hy... ondansetron dexamethasone | 18 Years - 88 Years | Ohio State University Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
